557 related articles for article (PubMed ID: 9517631)
1. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
2. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
Dieterich DT; Poles MA; Dicker M; Tepper R; Lew E
Am J Gastroenterol; 1993 Apr; 88(4):542-8. PubMed ID: 8385880
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
[TBL] [Abstract][Full Text] [Related]
4. Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.
Moretti S; Zikos P; Van Lint MT; Tedone E; Occhini D; Gualandi F; Lamparelli T; Mordini N; Berisso G; Bregante S; Bruno B; Bacigalupo A
Bone Marrow Transplant; 1998 Jul; 22(2):175-80. PubMed ID: 9707026
[TBL] [Abstract][Full Text] [Related]
5. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
6. Actinomyces infection of a cytomegalovirus esophageal ulcer in two patients with acquired immunodeficiency syndrome.
Poles MA; McMeeking AA; Scholes JV; Dieterich DT
Am J Gastroenterol; 1994 Sep; 89(9):1569-72. PubMed ID: 8079942
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome.
Wilcox CM; Straub RF; Schwartz DA
Am J Med; 1995 Feb; 98(2):169-76. PubMed ID: 7847433
[TBL] [Abstract][Full Text] [Related]
8. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
Bacigalupo A; van Lint MT; Tedone E; Moro F; Sanna MA; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
Bone Marrow Transplant; 1994 Jun; 13(6):753-8. PubMed ID: 7920310
[TBL] [Abstract][Full Text] [Related]
9. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
10. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
[TBL] [Abstract][Full Text] [Related]
11. [Cytomegalovirus infections in AIDS].
Raffi F
Rev Prat; 1995 Mar; 45(6):733-8. PubMed ID: 7754312
[TBL] [Abstract][Full Text] [Related]
12. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison.
Blanshard C; Benhamou Y; Dohin E; Lernestedt JO; Gazzard BG; Katlama C
J Infect Dis; 1995 Sep; 172(3):622-8. PubMed ID: 7658052
[TBL] [Abstract][Full Text] [Related]
13. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
[TBL] [Abstract][Full Text] [Related]
14. [Cytomegalovirus polyradiculomyelopathy in AIDS].
Jayaweera DT; Cassetti LI; Espinoza L; Lopardo GD; Hansman-Whiteman ML; Scerpella EG
Medicina (B Aires); 1998; 58(2):135-40. PubMed ID: 9706245
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
17. Foscarnet treatment in various cytomegalovirus infections.
Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868
[TBL] [Abstract][Full Text] [Related]
18. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease.
Balfour HH
Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708
[TBL] [Abstract][Full Text] [Related]
20. Management of cytomegalovirus infection in patients with acquired immunodeficiency syndrome.
Pau AK; Pitrak DL
Clin Pharm; 1990 Aug; 9(8):613-31. PubMed ID: 2167189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
